Home » Topics » Regulatory » Patents

Patents
RSS

Cure Biopharma patents gemcitabine prodrugs for cancer

Nov. 25, 2020

New antibodies for COVID-19 presented by University of Pittsburgh

Nov. 24, 2020

European researchers discover new NR1I3 agonists

Nov. 24, 2020

AiCuris synthesizes HBV capsid assembly inhibitors

Nov. 24, 2020

ViiV Healthcare divulges new HIV1 inhibitors

Nov. 24, 2020

Chinese researchers patent compounds for liver diseases

Nov. 24, 2020

Genfleet Therapeutics synthesizes KRAS inhibitors

Nov. 23, 2020

AiCuris presents new HBV inhibitors

Nov. 23, 2020

Beijing Jialin Pharmaceutical discloses new SMARCA2-targeting compounds

Nov. 23, 2020

Abbisko Therapeutics patents ROR-gammaT agonists

Nov. 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...